Defitelio (defibrotide) / IRCCS San Raffaele Hospital, Jazz 
Welcome,         Profile    Billing    Logout  
 22 Diseases   7 Trials   7 Trials   1018 News 
10 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Defitelio (defibrotide) / IRCCS San Raffaele Hospital, Jazz
DEFACOVID, NCT04348383 / 2020-001409-21: Defibrotide as Prevention and Treatment of Respiratory Distress and Cytokine Release Syndrome of Covid 19.

Completed
2b
156
Europe
Defibrotide, Placebo
Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia
COVID19
02/23
02/23
NCT04313036: 5-day Defibrotide Treatment for Hepatic SOS/VOD

Recruiting
2
24
US
Defibrotide
Loyola University
Sinusoidal Obstruction Syndrome, Veno-occlusive Disease, Bone Marrow Transplant Complications
05/22
08/22
NCT03805581: Defibrotide in Sickle Cell Disease-Related Acute Chest Syndrome

Completed
2
20
US
Defibrotide, Defitelio®
New York Medical College, Johns Hopkins University
Sickle Cell Disease, Acute Chest Syndrome
07/22
11/23
NCT04777422: Defibrotide in Children With High Risk Kawasaki Disease

Active, not recruiting
2
2
US
Defibrotide, Defitelio®
New York Medical College, Johns Hopkins University, Columbia University, New York University
Kawasaki Disease
10/23
06/24
DF in COVID19, NCT04652115: Defibrotide for the Treatment of Severe COVID-19

Recruiting
2
42
US
Defibrotide
Brigham and Women's Hospital, Jazz Pharmaceuticals
Covid19
09/24
03/25
NCT06182410: Defibrotide Prophylaxis of Transplant Associated-Thrombotic Microangiopathy for Neuroblastoma

Withdrawn
2
15
NA
Defibrotide, Noravid
University of California, San Francisco, Jazz Pharmaceuticals
Transplant-Associated Thrombotic Microangiopathy, Neuroblastoma, High-risk Neuroblastoma, Thrombotic Microangiopathies
05/27
05/27
NYMC-571, NCT02675959: Myeloablative Conditioning, Prophylactic Defibrotide and Haplo AlloSCT for Patients With Sickle Cell Disease

Recruiting
2
40
US
Defibrotide
New York Medical College, University of California, Los Angeles, Medical College of Wisconsin, Tufts Medical Center, Baylor College of Medicine, Johns Hopkins University, Dana-Farber Cancer Institute, Children's Hospital Los Angeles
Sickle Cell Disease
12/24
12/25
NCT05987124: Defibrotide Dose-escalation for SOS Post-HSCT

Recruiting
2
20
US
Defibrotide, Defitelio
New York Medical College
Sinusoidal Obstruction Syndrome, Veno-occlusive Disease
08/26
08/27
NCT00263978: Defibrotide Compassionate Use for Patients With Life Threatening Veno-Occlusive Disease of the Liver

No Longer Available
N/A
US
Defibrotide
Emory University
Liver Diseases
06/09
06/09
NCT00143546: Compassionate Use of Defibrotide for Patients With Veno-occlusive Disease of the Liver

No Longer Available
N/A
US
Defibrotide, Veno-occlusive disease, VOD, Hepatic veno-occlusive disease.
St. Jude Children's Research Hospital
Hepatic Veno-occlusive Disease
 
 

Download Options